While miR-145 can suppress ADAM17 expression in glioma cells, thereby inhibiting cell migration and invasion, whether miR-145 enhances TMZ sensitivity in GBM by regulating ADAM17 remains uncertain [13,23]. Here, ADAM17 is linked to glioblastoma.